The Cigna Group (VIE:CIGN)
Austria · Delayed Price · Currency is EUR | Market Cap | 62.98B -8.4% |
| Revenue (ttm) | 247.17B +7.8% |
| Net Income | 5.62B +27.9% |
| EPS | 21.17 +32.6% |
| Shares Out | n/a |
| PE Ratio | 11.21 |
| Forward PE | 8.83 |
| Dividend | 5.32 (2.20%) |
| Ex-Dividend Date | Sep 8, 2026 |
| Volume | n/a |
| Open | 239.70 |
| Previous Close | 241.40 |
| Day's Range | 239.70 - 240.70 |
| 52-Week Range | 210.90 - 268.15 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty p... [Read more]
Financial Performance
In 2025, The Cigna Group's revenue was $274.90 billion, an increase of 11.24% compared to the previous year's $247.12 billion. Earnings were $5.96 billion, an increase of 73.47%.
Financial numbers in USD Financial StatementsNews
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs
Industry-first connected benefits experience helps people access cash benefits when they need it most and gives employers more affordable coverage options BLOOMFIELD, Conn., Aug. 26, 2026 /PRNewswire/...
Cigna downgraded to Hold from Buy at Jefferies
Jefferies downgraded Cigna (CI) to Hold from Buy with a price target of $307, down from $336. The firm believes consensus estimates for Cigna look a “little high” with the…
Cigna downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Cigna (CI) to Outperform from Strong Buy with a price target of $320, down from $350. Cigna is a slower-growth story with limited near-term catalysts, while PBM…
Cigna price target raised to $305 from $302 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Cigna (CI) to $305 from $302 and keeps a Hold rating on the shares.
Cigna price target raised to $362 from $337 at Baird
Baird raised the firm’s price target on Cigna (CI) to $362 from $337 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results and…
Cigna price target raised to $361 from $338 at Guggenheim
Guggenheim raised the firm’s price target on Cigna (CI) to $361 from $338 and keeps a Buy rating on the shares on higher 2027 estimates after Cigna reported Q2 EPS…
Cigna price target raised to $307 from $305 at Wells Fargo
Wells Fargo raised the firm’s price target on Cigna (CI) to $307 from $305 and keeps an Equal Weight rating on the shares. The firm’s estimates modestly increase on higher…
Cigna price target raised to $310 from $304 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Cigna (CI) to $310 from $304 and keeps an Equal Weight rating on the shares.
The Cigna Group Earnings Call Transcript: Q2 2026
Q2 2026 saw revenues of $71.7B and adjusted EPS of $7.78, with both Evernorth and Cigna Healthcare exceeding expectations. Full-year adjusted EPS guidance was raised to at least $30.45, driven by strong specialty growth, biosimilar adoption, and disciplined execution.
The Cigna Group Earnings release: Q2 2026
The Cigna Group released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
The Cigna Group Quarterly report: Q2 2026
The Cigna Group has published its Q2 2026 quarterly earnings report on July 30, 2026.
Cigna raises FY26 adjusted EPS view to at least $30.45 from at least $30.35
Consensus $30.41. The company said, “The Cigna (CI) Group’s outlook for full year 2026 consolidated adjusted income from operations is at least $30.45 per share. Additionally, this outlook includes th...
As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit
The Cigna Group Thursday reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging the entire health insurance industry.
Cigna Group Lifts Outlook, Logs Higher Profit on Growth Across Businesses
Cigna Group lifted its outlook and reported a higher profit in the second quarter, driven by growth in both its healthcare and pharmacy-benefit businesses.
Cigna raises annual profit forecast on strength in health services unit
Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth in its pharmacy and specialty drug businesses.
The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
Total revenues for the second quarter 2026 increased 7% to $71.7 billion Shareholders' net income for the second quarter 2026 was $1.7 billion, or $6.29 per share Adjusted income from operations1 for ...
CI Global Asset Management Announces Risk Rating Changes for Two Funds
TORONTO--(BUSINESS WIRE)-- #CIFinancial--CI Global Asset Management announces risk rating changes for two mutual funds.
Cigna says AI tools to save customers $200 million in medical expenses over three years
Health insurer Cigna said on Thursday that the artificial intelligence tools it is employing to identify patients with chronic or complex conditions will save customers $200 million in medical costs...
Cigna Healthcare Expands AI-Enabled Personalized Support to Help More Customers Access Care Earlier and Improve Affordability
New capabilities will help 20% more customers with complex or chronic health needs access personalized clinical support earlier, reducing medical costs by $200M over three years BLOOMFIELD, Conn., Jul...
The Cigna Group Declares Quarterly Dividend
BLOOMFIELD, Conn., July 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on September 23, 20...
Justice Department expands antitrust probe into Claritev, Bloomberg says
The Justice Department is expanding an antitrust investigation into Claritev (CTEV) over allegations the company helped insurers, including UnitedHealth (UNH), CVS Health’s (CVS) Aetna and Cigna (CI),...
Cigna price target raised to $381 from $371 at Bernstein
Bernstein raised the firm’s price target on Cigna (CI) to $381 from $371 and keeps an Outperform rating on the shares ahead of quarterly results. The firm sees more potential…
The Cigna Group's Second Quarter 2026 Earnings Release Details
BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a confe...
Cigna invests $100 million in new AI-powered specialty pharmacy program
Cigna said on Wednesday its health services unit Evernorth has launched a new AI-powered specialty pharmacy program to reduce the time it takes to process prescriptions and improve customer service.
Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions
New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence BLOOMFIELD, Conn...